Company attributes
Industry
B2X
CEO
Founder
AngelList URL
Pitchbook URL
Legal Name
Sage Therapeutics, Inc.0
Legal classification
Date Incorporated
2010
Number of Employees (Ranges)
501 – 1,000
Email Address
ir@sagerx.com0
collaboration@sagerx.com0
medinfo@sagerx.com0
clinicaltrialsinquiry@sagerx.com0
media@sagerx.com0
Phone Number
+161729983800
Number of Employees
4710
Full Address
7751 Brier Creek Parkway Raleigh, NC 27617, USA0
215 1ST St Cambridge, MA, 02142-1213 United States0
CIK Number
Place of Incorporation
DUNS Number
9681649590
Founded Date
2010
Fax Number
617-299-83790
Total Funding Amount (USD)
93,000,000
Latest Funding Round Date
March 2014
Competitors
Stock Symbol
SAGE
Exchange
Glassdoor ID
Board of Directors
CTO
CFO
Former CEO
Latest Funding Type
NAICS Code
325,4120
CAGE Code
6DBP90
Patents Assigned (Count)
41
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Invested in
SIC Code
2,8340
Ticker Symbol
SAGE0
Wikidata ID
Sage Therapeutics is a biopharmaceutical company headquartered in Cambridge, Massachusetts and founded in 2010 by Douglas Covey and Steven Paul. The company develops medicines and therapies to treat disorders of the central nervous system.
Funding
Series A
On October 18, 2011 Sage Therapeutics closed their series A funding round with $35 million in funding from Third Rock Ventures.
Series B
On October 16, 2013 Sage Therapeutics closed their series B funding round with $20 million in funding from Third Rock Ventures and ARCH Venture Partners.
Series C
On March 13, 2014 Sage Therapeutics closed their series C funding round with $38 million in funding from Third Rock Ventures, OrbiMed, Foresite Capital, EcoR1 Capital, and ARCH Venture Partners.
Timeline
No Timeline data yet.
